Latest news
CytoSorbents (NASDAQ: CTSO) posts Q2 2026 revenue of $9.6M and narrows loss - Stock TitanStock Titan · Fri, 07 Aug 2026 20:07:30 GMTCytoSorbents plans early-2027 FDA filing for blood-thinner device - Stock TitanStock Titan · Thu, 06 Aug 2026 20:25:00 GMTCytoSorbents (Nasdaq: CTSO) flags going concern as cash falls to $5.9M - Stock TitanStock Titan · Thu, 06 Aug 2026 20:13:16 GMT